Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  GOODWIN ROBERT ALLEN II
2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2016
3. Issuer Name and Ticker or Trading Symbol
ORTHOFIX INTERNATIONAL N V [OFIX]
(Last)
(First)
(Middle)
3451 PLANO PKWY
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President Biologics
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

LEWISVILLE, TX 75056
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 27,920 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option 06/07/2009 06/07/2016 Common Stock 11,687 $ 39.24 D  
Stock Option 06/30/2009 06/30/2016 Common Stock 1,500 $ 38.11 D  
Stock Option   (2) 07/16/2023 Common Stock 10,000 $ 27.97 D  
Stock Option   (3) 09/26/2023 Common Stock 6,250 $ 21.78 D  
Stock Option   (4) 06/30/2024 Common Stock 7,725 $ 36.25 D  
Stock Option   (5) 06/30/2025 Common Stock 9,000 $ 33.12 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
GOODWIN ROBERT ALLEN II
3451 PLANO PKWY
LEWISVILLE, TX 75056
      President Biologics  

Signatures

/s/ Jeffrey M. Schumm, by power of attorney 03/21/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents (i) 4,839 shares directly owned; (ii) 11,931 time-based restricted stock awards in which 4,394 shares, 5,394 shares, 1,393 shares and 750 shares will vest in the remainder of 2016, 2017, 2018 and 2019 respectively; and (iii) 11,150 performance-based restricted stock awards of 5,150 shares and 6,000 shares granted under the 2014 Performance Vesting Restricted Stock Grant Agreement and the 2015 Performance Vesting Restricted Stock and Performance Share Unit Grant Agreement, respectively.
(2) These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 16, 2013.
(3) These stock options vest in 50% increments on September 26, 2016 and 2017.
(4) These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2014.
(5) These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.